Advertisement

Topics

German Biotech Starts Trials with a Personalized Cell Therapy for Multiple Cancers

06:57 EDT 21 Aug 2017 | Labiotech.eu

Immatics will start a first clinical trial to test IMA101, a personalized cell therapy with the potential to treat multiple types of solid tumors.  Based in Tübingen, Germany, Immatics has announced today the start of its first clinical trial testing its ...

This awesome article German Biotech Starts Trials with a Personalized Cell Therapy for Multiple Cancers appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: German Biotech Starts Trials with a Personalized Cell Therapy for Multiple Cancers

NEXT ARTICLE

More From BioPortfolio on "German Biotech Starts Trials with a Personalized Cell Therapy for Multiple Cancers"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...